Table 3

Mean (SE) lumbar spine bone mineral density (percentage change from baseline)

Etidronate (n=26)Placebo (n=23)
Week 264.33 (0.85)3-159 (22)3-a 0.57 (0.67) (19)3-a
Week 525.02 (1.20)3-159 3-150(21)0.47 (0.78) (18)
Week 785.09 (0.91)3-159(21)0.39 (1.10) (18)
Week 1045.12 (1.02)3-159 3-150(21)0.98 (1.47) (16)

  • ↵3-a Number of patients with available data.

  • ↵3-159 Significantly different from baseline, within group analysis.

  • ↵3-150 Significantly different from placebo (analysis at weeks 52 and 104 only).